新型隐球菌菌株中可引发保护性抗体的多糖表位的流行情况。
Prevalence in Cryptococcus neoformans strains of a polysaccharide epitope which can elicit protective antibodies.
作者信息
Cleare W, Mukherjee S, Spitzer E D, Casadevall A
机构信息
Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
出版信息
Clin Diagn Lab Immunol. 1994 Nov;1(6):737-40. doi: 10.1128/cdli.1.6.737-740.1994.
Abstract
Monoclonal antibody (MAb) 2H1 binds to an epitope in the capsule of Cryptococcus neoformans that can elicit protective antibodies. The binding of MAb 2H1 to C. neoformans strains was studied by agglutination, immunofluorescence, and phagocytosis assays. The MAb 2H1 epitope was present in all 21 isolates studied, including those recovered from patients with recurrent infections.
摘要
单克隆抗体（MAb）2H1与新型隐球菌荚膜中的一个表位结合，该表位可引发保护性抗体。通过凝集试验、免疫荧光试验和吞噬作用试验研究了MAb 2H1与新型隐球菌菌株的结合情况。在所研究的全部21株分离菌株中均存在MAb 2H1表位，包括从复发性感染患者体内分离出的菌株。
相似文献
1
Prevalence in Cryptococcus neoformans strains of a polysaccharide epitope which can elicit protective antibodies.
Clin Diagn Lab Immunol. 1994 Nov;1(6):737-40. doi: 10.1128/cdli.1.6.737-740.1994.
2
In vitro and in vivo stability of a Cryptococcus neoformans [corrected] glucuronoxylomannan epitope that elicits protective antibodies.
Infect Immun. 1999 Jun;67(6):3096-107. doi: 10.1128/IAI.67.6.3096-3107.1999.
3
4
Production and characterization of monoclonal antibodies specific for Cryptococcus neoformans capsular polysaccharide.
Infect Immun. 1987 Aug;55(8):1895-9. doi: 10.1128/iai.55.8.1895-1899.1987.
5
Antibody interactions with the capsule of Cryptococcus neoformans.
Infect Immun. 2000 Jun;68(6):3642-50. doi: 10.1128/IAI.68.6.3642-3650.2000.
6
Contribution of epitope specificity to the binding of monoclonal antibodies to the capsule of Cryptococcus neoformans and the soluble form of its major polysaccharide, glucuronoxylomannan.
Clin Diagn Lab Immunol. 2003 Mar;10(2):252-8. doi: 10.1128/cdli.10.2.252-258.2003.
7
Peptide libraries define the fine specificity of anti-polysaccharide antibodies to Cryptococcus neoformans.
J Mol Biol. 1996 Aug 9;261(1):11-22. doi: 10.1006/jmbi.1996.0438.
8
Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains.
Infect Immun. 1995 Sep;63(9):3353-9. doi: 10.1128/iai.63.9.3353-3359.1995.
9
Protective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles.
Infect Immun. 2004 Aug;72(8):4810-8. doi: 10.1128/IAI.72.8.4810-4818.2004.
10
Cryptococcus neoformans infection can elicit protective antibodies in mice.
Can J Microbiol. 1994 Oct;40(10):888-92. doi: 10.1139/m94-141.
引用本文的文献
1
The capsule of the fungal pathogen Cryptococcus neoformans.
Adv Appl Microbiol. 2009;68:133-216. doi: 10.1016/S0065-2164(09)01204-0.
2
Biological activity of a mouse-human chimeric immunoglobulin G2 antibody to Cryptococcus neoformans polysaccharide.
Clin Diagn Lab Immunol. 2002 Jan;9(1):201-4. doi: 10.1128/cdli.9.1.201-204.2002.
3
In vitro and in vivo stability of a Cryptococcus neoformans [corrected] glucuronoxylomannan epitope that elicits protective antibodies.
Infect Immun. 1999 Jun;67(6):3096-107. doi: 10.1128/IAI.67.6.3096-3107.1999.
4
Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies.
Antimicrob Agents Chemother. 1998 Jun;42(6):1437-46. doi: 10.1128/AAC.42.6.1437.
5
The different binding patterns of two immunoglobulin M monoclonal antibodies to Cryptococcus neoformans serotype A and D strains correlate with serotype classification and differences in functional assays.
Clin Diagn Lab Immunol. 1998 Mar;5(2):125-9. doi: 10.1128/CDLI.5.2.125-129.1998.
6
Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains.
Infect Immun. 1995 Sep;63(9):3353-9. doi: 10.1128/iai.63.9.3353-3359.1995.
7
Monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan enhance fluconazole efficacy.
Antimicrob Agents Chemother. 1995 Jul;39(7):1398-405. doi: 10.1128/AAC.39.7.1398.
本文引用的文献
1
Effects of strain variation, serotype, and structural modification on kinetics for activation and binding of C3 to Cryptococcus neoformans.
Infect Immun. 1993 Jul;61(7):2966-72. doi: 10.1128/iai.61.7.2966-2972.1993.
2
Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection.
Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3636-40. doi: 10.1073/pnas.90.8.3636.
3
Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole.
Antimicrob Agents Chemother. 1993 Jun;37(6):1383-6. doi: 10.1128/AAC.37.6.1383.
4
Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B.
Antimicrob Agents Chemother. 1994 Mar;38(3):580-7. doi: 10.1128/AAC.38.3.580.
5
Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice.
Infect Immun. 1994 Mar;62(3):1079-88. doi: 10.1128/iai.62.3.1079-1088.1994.
6
Persistence of initial infection in recurrent Cryptococcus neoformans meningitis.
Lancet. 1993 Mar 6;341(8845):595-6. doi: 10.1016/0140-6736(93)90354-j.
7
Mouse-human immunoglobulin G1 chimeric antibodies with activities against Cryptococcus neoformans.
Antimicrob Agents Chemother. 1994 Jul;38(7):1507-14. doi: 10.1128/AAC.38.7.1507.
8
Restriction fragment length polymorphism analysis of Cryptococcus neoformans isolates from environmental (pigeon excreta) and clinical sources in New York City.
J Clin Microbiol. 1994 May;32(5):1188-92. doi: 10.1128/jcm.32.5.1188-1192.1994.
9
Opsonization of encapsulated Cryptococcus neoformans by specific anticapsular antibody.
Infect Immun. 1981 Mar;31(3):978-84. doi: 10.1128/iai.31.3.978-984.1981.
10
The genetic basis of antibody production: a single heavy chain variable region gene encodes all molecules bearing the dominant anti-arsonate idiotype in the strain A mouse.
Eur J Immunol. 1983 Feb;13(2):123-32. doi: 10.1002/eji.1830130207.
Zotero 插件